Richard J. Hawkins is Director at SCICLONE PHARMACEUTICALS INC (SCLN). They have made 18 open-market trades across 4 companies since 2014, most recently 2026-10-01.
CIK 0001307632
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $162K since 2022, against 12 sales. Across 6 scored buys the stock is down 24.2% at ninety days, and 29.5 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 50% | 17% |
| Avg Move | +1.2% | -1.5% | -24.2% |
| Alpha | -0.1% | -4.3% | -29.5% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SVRA | BUY | 2025-06-20 | 2025-06-23 | $2.04 | $98K | +0.0% | +13.7% | +59.4% |
| SVRA | SELL | 2024-12-16 | 2024-12-16 | $3.32 | $27K | -0.9% | -2.8% | -11.6% |
| PSTV | BUY | 2024-09-13 | 2024-09-17 | $1.50 | $6K | +15.6% | -11.9% | -26.9% |
| PSTV | BUY | 2024-09-12 | 2024-09-16 | $1.35 | $8K | -2.5% | -9.5% | -25.9% |
| PSTV | BUY | 2024-05-08 | 2024-05-10 | $2.04 | $10K | -5.2% | -3.9% | -32.6% |
| LUMO | BUY | 2022-09-21 | 2022-09-23 | $8.84 | $21K | -2.1% | +1.5% | -57.3% |
| LUMO | BUY | 2022-09-19 | 2022-09-21 | $8.72 | $18K | +1.5% | +1.1% | -61.7% |
| SVRA | SELL | 2019-05-15 | 2019-05-16 | $11.16 | $116K | -4.4% | -79.5% | -80.2% |
| SVRA | SELL | 2019-05-14 | 2019-05-16 | $11.07 | $162K | -4.4% | -79.5% | -80.2% |
| SVRA | SELL | 2019-05-14 | 2019-05-16 | $11.11 | $555K | -4.4% | -79.5% | -80.2% |
| SCLN | SELL | 2016-08-12 | 2016-08-16 | $10.37 | $311K | -1.1% | -3.2% | -2.5% |
| SCLN | SELL | 2016-08-12 | 2016-08-16 | $10.37 | $311K | -1.1% | -3.2% | -2.5% |
| SCLN | SELL | 2015-06-01 | 2015-06-02 | $9.27 | $42K | -15.6% | -3.7% | -3.7% |
| SCLN | SELL | 2015-05-29 | 2015-06-01 | $9.32 | $97K | -15.6% | -3.7% | -3.7% |
| SCLN | SELL | 2015-05-26 | 2015-05-26 | $9.44 | $113K | -15.6% | -3.7% | -3.7% |
| SCLN | SELL | 2015-05-21 | 2015-05-26 | $9.71 | $36K | -15.6% | -3.7% | -3.7% |
| SCLN | SELL | 2015-05-14 | 2015-05-18 | $9.16 | $172K | -15.6% | -3.7% | -3.7% |
| SCLN | SELL | 2014-12-10 | 2014-12-11 | $8.79 | $137K | -15.6% | -3.7% | -3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.